Latest News
- Freight Surge and Gulf Tensions Threaten India’s Pharma Exports; Industry Flags Potential ?5,000-Crore Impact
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
Moscow manufacturer of veterinary drugs gains access to the Turkish market
- By Newsdesk
- Moscow
- Jun 28, 2023
The Moscow-based company, "Vetbiohim," has received certification for its veterinary drug production facility, ensuring its compliance with the GMP (Good Manufacturing Practice) standard of the Republic of Turkey. This international certification guarantees the quality of the company's products and confirms their adherence to international requirements.
In 2022, "Vetbiohim" constructed a manufacturing plant within the Special Economic Zone, investing 1.6 billion rubles in the project. The company has successfully commenced the production of 36 vaccines for both domestic and agricultural animals. Additionally, they have developed four serum and immunoglobulin preparations, as well as 56 types of test systems to aid in the diagnosis of various diseases.
Thanks to the GMP certification issued by the Republic of Turkey, the Russian exporter now possesses the authorization to distribute its pharmaceutical products not only within the Turkish market but also in the global market.